|
US5744593A
(en)
*
|
1996-02-15 |
1998-04-28 |
Heska Corporation |
Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules
|
|
US6369106B1
(en)
*
|
1996-12-26 |
2002-04-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
|
|
US6896899B2
(en)
*
|
1996-12-31 |
2005-05-24 |
Antioxidant Pharmaceuticals Corp. |
Pharmaceutical preparations of glutathione and methods of administration thereof
|
|
WO1999026657A1
(en)
*
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
|
US20080275104A1
(en)
*
|
1997-11-25 |
2008-11-06 |
Musc Foundation For Research Development |
Methods of treating juvenile type 1 diabetes mellitus
|
|
US20040072138A1
(en)
*
|
1997-11-25 |
2004-04-15 |
Medical University Of South Carolina |
Attenuation of ischemia/reperfusion injury
|
|
JP4643004B2
(ja)
*
|
1998-01-06 |
2011-03-02 |
シーラス コーポレイション |
生体材料中の病原体不活性化剤をクエンチするための方法
|
|
US20070142267A1
(en)
*
|
1998-11-23 |
2007-06-21 |
Novelos Therapeutics, Inc. |
Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
|
|
US6312734B1
(en)
*
|
1998-11-23 |
2001-11-06 |
Novelos Therapeutics, Inc. |
Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
|
|
RU2144374C1
(ru)
*
|
1998-11-23 |
2000-01-20 |
Закрытое акционерное общество "ВАМ" |
Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
|
|
GB2367489B
(en)
*
|
2000-07-31 |
2005-02-09 |
Mars Inc |
Use of antioxidants
|
|
WO2001012166A2
(en)
*
|
1999-08-17 |
2001-02-22 |
University Of Saskatchewan Technologies Inc. |
Improved treatment for acute physical insult to the central nervous system
|
|
US6642274B1
(en)
|
1999-09-09 |
2003-11-04 |
Gary W. Neal |
Methods and compositions for preventing and treating prostate disorders
|
|
EP1214038A2
(en)
*
|
1999-09-09 |
2002-06-19 |
Androsolutions, Inc. |
Methods and compositions for preventing and treating prostate disorders
|
|
EP1086695B1
(en)
*
|
1999-09-21 |
2004-12-22 |
Enzo Leone |
Antiviral compositions comprising yohimbine as active principle
|
|
AU4085201A
(en)
*
|
2000-03-15 |
2001-09-24 |
Imperial College Innovations Limited |
Pharmaceutical composition
|
|
WO2001072311A1
(en)
*
|
2000-03-28 |
2001-10-04 |
Delorenzo Robert J |
Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death
|
|
GB0008689D0
(en)
*
|
2000-04-07 |
2000-05-31 |
Nokia Networks Oy |
A method and system for processing signals
|
|
RU2258509C2
(ru)
*
|
2000-04-07 |
2005-08-20 |
Санг Геон КИМ |
Применение олтипраза для профилактики и лечения фиброза и цирроза печени и фармацевтическая композиция, содержащая олтипраз
|
|
WO2001085013A2
(en)
*
|
2000-05-09 |
2001-11-15 |
Nitromed, Inc. |
Infrared thermography and methods of use
|
|
US6528520B2
(en)
*
|
2000-08-15 |
2003-03-04 |
Cpd, Llc |
Method of treating the syndrome of coronary heart disease risk factors in humans
|
|
US6846831B2
(en)
|
2000-08-15 |
2005-01-25 |
Cpd, Llc |
Method of treating the syndrome of lipodystrophy
|
|
WO2002026223A2
(en)
*
|
2000-09-29 |
2002-04-04 |
Board Of Trustees Operating Michigan State University |
Catecholamine pharmaceutical compositions and methods
|
|
US7179791B2
(en)
*
|
2001-01-11 |
2007-02-20 |
Duke University |
Inhibiting GS-FDH to modulate NO bioactivity
|
|
US20020169112A1
(en)
*
|
2001-05-08 |
2002-11-14 |
Luc Montagnier |
Combined treatments and methods for treatment of mycoplasma and mycoplasma-like organism infections
|
|
US20030096770A1
(en)
*
|
2001-07-11 |
2003-05-22 |
Krotz Achim H. |
Enhancement of the stability of oligonucleotides comprising phosphorothioate linkages by addition of water-soluble antioxidants
|
|
WO2003025831A2
(en)
*
|
2001-09-14 |
2003-03-27 |
Roke Manor Research Limited |
Tag and tagging system
|
|
US6726809B2
(en)
*
|
2001-09-26 |
2004-04-27 |
Albany International Corp. |
Industrial process fabric
|
|
WO2003032908A2
(en)
*
|
2001-10-16 |
2003-04-24 |
University Of Kansas |
Novel prodrugs of n-h bond-containing compounds and methods of making thereof
|
|
US20040241256A1
(en)
*
|
2002-12-05 |
2004-12-02 |
Seymour Ehrenpreis |
Medicinal compositions & therapeutic methods
|
|
EP1474158B1
(en)
*
|
2001-12-18 |
2009-10-14 |
Brassica Foundation for Chemoprotection Research, Inc. |
Prevention and treatment of oxidative stress disorders by compounds which elevate intracellular levels of glutathione or phase ii detoxification enzymes
|
|
US20030194453A1
(en)
*
|
2002-04-15 |
2003-10-16 |
Coleman Henry D. |
Dietary supplement
|
|
US20060099239A1
(en)
*
|
2002-04-15 |
2006-05-11 |
Coleman Henry D |
Dietary supplement for promoting removal of heavy metals from the body
|
|
US20040213829A1
(en)
*
|
2002-04-15 |
2004-10-28 |
Coleman Henry D. |
Dietary supplement
|
|
US20090011048A1
(en)
*
|
2002-04-16 |
2009-01-08 |
Coleman Henry D |
Dietary Supplement For Promoting Removal Of Heavy Metals From The Body
|
|
AU2003265321A1
(en)
*
|
2002-05-03 |
2003-11-17 |
Luc Montagnier |
Treatments and methods for the treatment, diagnosis and prophylaxis
|
|
US20070065497A1
(en)
*
|
2005-09-20 |
2007-03-22 |
Guilford Frederick T |
Combination and method using EDTA combined with glutathione in the reduced state encapsulated in a liposome to facilitate the method of delivery of the combination as an oral, topical, intraoral or transmucosal, for anti-thrombin effect and for anti-platelet aggregation and measurement of efficacy
|
|
US20100316700A1
(en)
*
|
2002-11-07 |
2010-12-16 |
Guilford F Timothy |
Systemic administration of liposomal reduced glutathione for the decorporation of radioactive materials and non-radioactive mercury
|
|
WO2004055165A2
(en)
*
|
2002-12-13 |
2004-07-01 |
St. Jude Children's Research Hospital |
Glutathione-s-transferase test for susceptibility to parkinson's
|
|
DE10300222A1
(de)
*
|
2003-01-03 |
2004-07-15 |
MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH |
Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen
|
|
US20040229815A1
(en)
*
|
2003-01-03 |
2004-11-18 |
Nagasawa Herbert T. |
Methods for reducing oxidative stress in a cell with a sulfhydryl protected glutathione prodrug
|
|
US7781539B2
(en)
*
|
2003-02-21 |
2010-08-24 |
Metabolix Inc. |
PHA blends
|
|
ATE377060T1
(de)
*
|
2003-02-21 |
2007-11-15 |
Metabolix Inc |
Pha-klebstoffe
|
|
US8076060B2
(en)
*
|
2003-08-04 |
2011-12-13 |
Emil William Chynn |
Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
|
|
JP2005104852A
(ja)
*
|
2003-09-29 |
2005-04-21 |
Kyowa Hakko Kogyo Co Ltd |
モービリウィルス感染症の予防または治療用組成物
|
|
US20070276024A1
(en)
*
|
2003-10-09 |
2007-11-29 |
Inverseon , Inc. |
Methods for Treating Diseases and Conditions with Inverse Agonists and for Screening for Agents Acting as Inverse Agonists
|
|
US20050143300A1
(en)
*
|
2003-10-10 |
2005-06-30 |
Ma Jian-Xing |
Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
|
|
US20050250694A1
(en)
*
|
2003-10-10 |
2005-11-10 |
Ma Jian-Xing |
Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
|
|
BRPI0415409A
(pt)
*
|
2003-10-15 |
2006-12-05 |
Probiodrug Ag |
uso de efetuadores de ciclases de glutaminila e glutamato
|
|
US20050130897A1
(en)
*
|
2003-12-11 |
2005-06-16 |
Ma Jian-Xing |
Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
|
|
CA2548313A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Musc Foundation For Research Development |
Methods and compositions for the prevention and treatment of inflammatory diseases or conditions
|
|
JP2007517126A
(ja)
*
|
2003-12-30 |
2007-06-28 |
メタボリックス インコーポレイティッド |
増核剤
|
|
US20050202521A1
(en)
*
|
2004-03-10 |
2005-09-15 |
Albert Crum |
Methods of assessing the need for and the effectiveness of therapy with antioxidants
|
|
US8217084B2
(en)
*
|
2004-05-24 |
2012-07-10 |
Allium Vitalis Incorporated |
Medicinal products incorporating bound organosulfur groups
|
|
JP5066448B2
(ja)
*
|
2004-09-03 |
2012-11-07 |
協和発酵バイオ株式会社 |
口内炎の予防または治療のための組成物および方法
|
|
US20060083724A1
(en)
*
|
2004-10-01 |
2006-04-20 |
Hilst Todd W |
Compositions for the treatment of femal sexual dysfunction
|
|
JP5112876B2
(ja)
*
|
2004-11-07 |
2013-01-09 |
エフ． ギルフォード ティモシー |
還元型グルタチオン経口投与のためのリポソーム処方物
|
|
JP2008524123A
(ja)
*
|
2004-12-21 |
2008-07-10 |
クリティカル ケア コネクションズ インク |
治療用栄養組成物又は組合せ、及びそれらの使用方法
|
|
CA2595606C
(en)
*
|
2005-01-27 |
2014-12-16 |
Erimos Pharmaceuticals Llc |
Oral formulations for delivery of catecholic butanes including ndga compounds
|
|
CN101150955B
(zh)
*
|
2005-01-27 |
2013-04-17 |
埃里莫斯医药品有限公司 |
递送包括ndga化合物的儿茶酚丁烷的口服制剂
|
|
WO2006091610A2
(en)
*
|
2005-02-23 |
2006-08-31 |
The Brigham And Women's Hospital, Inc. |
Inhibitors of enveloped virus infectivity
|
|
ES2731298T3
(es)
|
2005-05-27 |
2019-11-14 |
Univ North Carolina Chapel Hill |
Partículas de liberación de óxido nítrico para agentes terapéuticos de óxido nítrico y aplicaciones biomédicas
|
|
US20070004639A1
(en)
*
|
2005-07-01 |
2007-01-04 |
Bodybio, Inc. |
Methods and compositions for treating Parkinson's disease
|
|
CA2615319A1
(en)
*
|
2005-07-13 |
2007-01-18 |
Al Czap |
Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof
|
|
WO2007033211A2
(en)
*
|
2005-09-12 |
2007-03-22 |
The Board Of Regents Of The University Of Texas System |
Regulation of brain natriuretic peptide and catecholamines for the treatment of cardiovascular diseases
|
|
GB2430364A
(en)
*
|
2005-09-22 |
2007-03-28 |
Carl Ernest Alexander |
Soft agar bolus for oral drug delivery
|
|
US8093207B2
(en)
*
|
2005-12-09 |
2012-01-10 |
Unigene Laboratories, Inc. |
Fast-acting oral peptide pharmaceutical products
|
|
EA010926B1
(ru)
*
|
2006-01-20 |
2008-12-30 |
Леонид Андреевич Кожемякин |
Средство для лечения туберкулеза глаз, способ его получения и применения
|
|
US20090047340A1
(en)
*
|
2006-03-29 |
2009-02-19 |
Guilford F Timothy |
Liposomal reduced glutathione and 1-arginine, including with other ingredient(s), capable of multipath administration for reversal and prevention of obesity and for mitochondrial biogenesis
|
|
CA2664341C
(en)
|
2006-10-05 |
2018-11-06 |
Ikaria, Inc. |
Liquid chalcogenide compositions and methods of manufacturing and using the same
|
|
WO2008112887A1
(en)
*
|
2007-03-13 |
2008-09-18 |
Musc Foundation For Research Development |
Methods of treating juvenile type 1 diabetes mellitus
|
|
US20080287341A1
(en)
*
|
2007-05-18 |
2008-11-20 |
Danyang Chen |
Treatment of vascular abnormalities using nanoparticles
|
|
WO2009003061A1
(en)
|
2007-06-25 |
2008-12-31 |
Fred Hutchinson Cancer Research Center |
Methods and compositions regarding polychalcogenide compositions
|
|
GB0722923D0
(en)
*
|
2007-11-22 |
2008-01-02 |
Uhi Millennium Inst |
Improved anti-platelet compositions
|
|
WO2009099132A1
(ja)
*
|
2008-02-05 |
2009-08-13 |
Kyowa Hakko Bio Co., Ltd. |
グルタチオンの保存安定性向上方法
|
|
JP5499714B2
(ja)
*
|
2008-02-15 |
2014-05-21 |
味の素株式会社 |
腸管免疫賦活剤
|
|
EP2334279A4
(en)
*
|
2008-10-16 |
2013-03-20 |
Novan Inc |
STAIN OXIDE RELEASING PARTICLES FOR MOUTH CARE APPLICATIONS
|
|
JP5208028B2
(ja)
*
|
2009-03-16 |
2013-06-12 |
学校法人帝京大学 |
Ｅｄ評価方法
|
|
US8313456B2
(en)
*
|
2009-06-30 |
2012-11-20 |
Palo Alto Research Center Incorporated |
Drug-transfer device, drug-delivery system incorporating the same, methods of fabricating the same, and methods of enabling administration of a drug
|
|
CA2771389C
(en)
|
2009-08-21 |
2019-04-09 |
Novan, Inc. |
Wound dressings, methods of using the same and methods of forming the same
|
|
WO2011022652A1
(en)
|
2009-08-21 |
2011-02-24 |
Novan, Inc. |
Topical gels
|
|
US20110064828A1
(en)
*
|
2009-09-11 |
2011-03-17 |
Novelos Therapeutics, Incorporated |
Treatment of metastatic tumors and other conditions
|
|
BR112012008508A2
(pt)
*
|
2009-10-13 |
2017-06-13 |
Novan Inc |
revestimento de sol-gel, substrato, método para produzir um revestimento de sol-gel
|
|
WO2011091807A1
(en)
*
|
2010-01-31 |
2011-08-04 |
Abdelrahman Shata Mohammed Shata |
Anticoagulant and glutathione for treatment of cancer
|
|
US8591876B2
(en)
|
2010-12-15 |
2013-11-26 |
Novan, Inc. |
Methods of decreasing sebum production in the skin
|
|
WO2012118829A2
(en)
|
2011-02-28 |
2012-09-07 |
Novan, Inc. |
Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
|
|
US20150011463A1
(en)
*
|
2012-02-15 |
2015-01-08 |
Kyowa Hakko Bio Co., Ltd. |
Agent for preventing or ameliorating vascular endothelial malfunction
|
|
US20130323324A1
(en)
*
|
2012-06-01 |
2013-12-05 |
Franco Cavaleri |
Vanadium and vanadyl amino acid complexes
|
|
US20140179615A1
(en)
*
|
2012-07-12 |
2014-06-26 |
Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd. |
Glutathione and Acetaminophen Composition and Preparation Method Thereof
|
|
CN109054254B
(zh)
|
2012-08-17 |
2021-02-02 |
Cj第一制糖株式会社 |
用于聚合物共混物的生物基橡胶改性剂
|
|
ES2659199T3
(es)
*
|
2012-09-28 |
2018-03-14 |
Kyowa Hakko Bio Co., Ltd. |
Agente para aumentar la inmunidad que contiene glutatión
|
|
US20140100283A1
(en)
*
|
2012-10-05 |
2014-04-10 |
Atlantic Pro Nutrients, Inc. dba XYMOGEN |
Method to Increase Absorption and Bioavailability of Oral Glutathione
|
|
CN104955468A
(zh)
*
|
2013-01-21 |
2015-09-30 |
协和发酵生化株式会社 |
一氧化氮浓度增高剂
|
|
EP3004225A1
(en)
|
2013-05-30 |
2016-04-13 |
Metabolix, Inc. |
Recyclate blends
|
|
PL3639828T3
(pl)
|
2013-12-24 |
2022-05-02 |
Virginia Commonwealth University |
Zastosowanie utlenowanych siarczanów cholesterolu (ocs) w leczeniu ostrej niewydolności wątroby
|
|
MX386702B
(es)
|
2014-02-10 |
2025-03-19 |
Fred Hutchinson Cancer Center |
Tratamiento con halogeno de ataque cardiaco y lesion isquemica.
|
|
KR20230107890A
(ko)
*
|
2014-09-15 |
2023-07-18 |
사운드 파마슈티칼스 인코퍼레이티드 |
정신병적 장애를 치료하기 위한 방법 및 조성물
|
|
AU2015330807A1
(en)
*
|
2014-10-09 |
2017-04-13 |
Albert Crum |
Protective metallothionein analog compounds, their compositions and use thereof in the treatment of pathogenic diseases
|
|
US20160367620A1
(en)
*
|
2015-06-19 |
2016-12-22 |
Harry B. Demopoulos |
Glutathione
|
|
CA3044804A1
(en)
*
|
2015-11-25 |
2017-06-01 |
Molecular Defenses Corporation |
Pharmaceutical formulations
|
|
US10702590B2
(en)
*
|
2016-04-12 |
2020-07-07 |
Script Essentials, Llc |
Compositions and methods for treating thyroid disease
|
|
US20180008665A1
(en)
*
|
2016-07-05 |
2018-01-11 |
CanTrust LifeScience Corp. |
Methods of treating and preventing gout and lead nephropathy
|
|
AU2017362500B2
(en)
|
2016-11-17 |
2024-09-26 |
Renovion, Inc. |
Treatment of Respiratory Tract Diseases and Infections with Ascorbic Acid Compositions
|
|
BR112020009910A2
(pt)
|
2017-11-17 |
2020-11-03 |
Renovion, Inc. |
composições de ácido ascórbico estáveis e métodos de usar as mesmas
|
|
US10722465B1
(en)
|
2017-12-08 |
2020-07-28 |
Quicksilber Scientific, Inc. |
Transparent colloidal vitamin supplement
|
|
US11344497B1
(en)
|
2017-12-08 |
2022-05-31 |
Quicksilver Scientific, Inc. |
Mitochondrial performance enhancement nanoemulsion
|
|
US11291702B1
(en)
|
2019-04-15 |
2022-04-05 |
Quicksilver Scientific, Inc. |
Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method
|
|
EP3733197A1
(en)
*
|
2019-04-30 |
2020-11-04 |
Stephen N. Pitcher |
Anaerobic antioxidant composition
|
|
JPWO2022168169A1
(https=)
*
|
2021-02-02 |
2022-08-11 |
|
|
|
KR20240131358A
(ko)
|
2022-01-04 |
2024-08-30 |
레노비온, 아이엔씨. |
글루타치온 염을 포함하는 수용액
|
|
IT202200007238A1
(it)
*
|
2022-04-12 |
2023-10-12 |
Uriach Italy S R L |
Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
|
|
IT202200007232A1
(it)
*
|
2022-04-12 |
2023-10-12 |
Uriach Italy S R L |
Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
|
|
WO2023199241A1
(en)
*
|
2022-04-12 |
2023-10-19 |
URIACH ITALY S.r.l. |
Composition comprising lipoic acid, vitamin d and glutathione, uses thereof, and pharmaceutical and nutraceutical compositions thereof
|
|
IT202200007229A1
(it)
*
|
2022-04-12 |
2023-10-12 |
Uriach Italy S R L |
Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
|
|
CA3255655A1
(en)
*
|
2022-04-12 |
2023-10-19 |
URIACH ITALY S.r.l. |
Composition comprising N-acetylcysteine, vitamin D, and preferably glutathione, associated uses, and related pharmaceutical and nutraceutical compositions
|
|
KR102602347B1
(ko)
*
|
2022-05-09 |
2023-11-15 |
천현수 |
위장내 발암성 엔-니트로사민 생성 억제 및 장내 산화질소 생성 촉진용 천연 조성물 및 이의 용도
|